Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Cantor Fitzgerald
Cerilliant
Johnson and Johnson
Chinese Patent Office
AstraZeneca
Chubb
Moodys
US Department of Justice
Cipla

Generated: February 19, 2018

DrugPatentWatch Database Preview

CYPROHEPTADINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Cyproheptadine Hydrochloride patents expire, and what generic alternatives are available?

Cyproheptadine Hydrochloride is a drug marketed by Actavis Mid Atlantic, Bio-pharm Inc, Halsey, Lyne, Morton Grove, Naska, Pharm Assoc, Silarx Pharms Inc, Ailex Pharms Llc, Am Therap, Apex Pharms Inc, Appco Pharma Llc, Ascot, Chartwell Rx, Duramed Pharms Barr, Fosun Pharma, Ingenus Pharms Nj, Ivax Sub Teva Pharms, Kv Pharm, Md Pharm, Mountain, Mylan, Par Pharm, Pioneer Pharms, Pliva, Santos Biotech, Superpharm, Vitarine, Watson Labs, and Zydus Pharms Usa Inc. and is included in thirty-three NDAs.

The generic ingredient in CYPROHEPTADINE HYDROCHLORIDE is cyproheptadine hydrochloride. There are six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the cyproheptadine hydrochloride profile page.

US Patents and Regulatory Information for CYPROHEPTADINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 086580-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Superpharm CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087405-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 208938-001 May 19, 2017 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vitarine CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087284-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Actavis Mid Atlantic CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 086833-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ingenus Pharms Nj CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 205087-001 Sep 23, 2015 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Pharm CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 087129-001 Approved Prior to Jan 1, 1982 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharm Assoc CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 091295-001 Mar 28, 2013 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lyne CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 040668-001 Jun 28, 2006 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Appco Pharma Llc CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 206553-001 Nov 29, 2016 AA RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Dow
Cipla
Healthtrust
Federal Trade Commission
Fuji
Medtronic
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot